Question 1

Has Bacil Pharma Ltd. been shortlisted under Additional Surveillance Measure (ASM)?

Accepted Answer

No, Bacil Pharma Ltd. has not been shortlisted under Additional Surveillance Measure (ASM).

Question 2

Has Bacil Pharma Ltd. been shortlisted under Graded Surveillance Measure (GSM)?

Accepted Answer

No, Bacil Pharma Ltd. has not been shortlisted under Graded Surveillance Measure (GSM).

Question 3

When did Bacil Pharma Ltd. exit Graded Surveillance Measure (GSM)?

Accepted Answer

Bacil Pharma Ltd. exited Graded Surveillance Measure (GSM) on 04 Apr, 2025.

Question 4

What is Graded Surveillance Measure (GSM)?

Accepted Answer

Graded Surveillance Measure (GSM) is one of many surveillance measures implemented, by SEBI and Exchanges, on securities with price not commensurate with financial health and fundamentals like Earnings, Book value, Fixed assets, Net-worth, P/E multiple, Market Capitalisation etc.

Question 5

What are the main objectives of Graded Surveillance Measure (GSM)?

Accepted Answer

Alert and advice investors to be extra cautious while dealing in these securities.
Advise market participants to carry out necessary due diligence while dealing in these securities.

Question 6

Where can more details on Graded Surveillance Measure (GSM) be found?

Accepted Answer

FAQ booklet on GSM by BSE
GSM page on BSE website

Question 7

Should shortlisting under Graded Surveillance Measure (GSM) be construed as an adverse action against the concerned company/entity?

Accepted Answer

The shortlisting of securities under Graded Surveillance Measure (GSM) is purely on account of market surveillance and it should not be construed as an adverse action against the concerned company/entity.

Question 8

What are the criteria for shortlisting scrips under Graded Surveillance Measure (GSM) framework?

Accepted Answer

The detailed criteria for shortlisting & review of securities under GSM Framework is given below:

Criteria I:
The following criteria shall be made applicable for inclusion of securities under GSM Framework.

Securities with latest available Net worth (Share Capital + Reserves & Surplus – debit balance in P&L) less than or equal to Rs. 10 crores;

AND

Securities with latest available Net Fixed Assets (Tangible Assets + Capital Work in Progress) less than or equal to Rs. 25 crores;

AND

Securities with PE greater than 2 times PE of Benchmark Index (Nifty 500) OR negative PE.

The following securities shall be excluded from the process of shortlisting of securities under GSM:

Securities where the price discovery is yet to take place as per the provision of SEBI circulars CIR/MRD/DP/01/2012 and CIR/MRD/DP/02/2012 dated January 20, 2012.
Securities already under suspension;
Securities on which derivative products are available;
Securities as a part of any index (NSE or BSE);
Public Sector Enterprises and its subsidiaries, if available;
Securities listed during last 1 year through Initial Public Offering (IPO);
Securities which have paid a dividend for each of the last three preceding years;
Securities with Institutional holding greater than 10% only if the following conditions are met:

If the promoter entity has not offloaded any share in the last 5 years;

AND

The current trading price of the security is within the range of High & Low price in last 3 years of the respective security.

Securities listed through Scheme of Arrangement involving Merger / Demerger during last 1 year:

In case of demerger, the following condition shall be applicable:

If the parent company is under purview of GSM, the resultant demerged companies shall also attract GSM.
If the parent company is not under purview of GSM, the resultant demerged companies shall not be part of GSM at the time of demerger and shall be considered during the subsequent quarterly review.

In case of merger of companies, if any of the securities at time of merger are under the purview of GSM, then the same shall be continued on the resultant entity.

Criteria II:
The following criteria shall be made applicable for inclusion of securities.

Securities with full market capitalization less than Rs. 25 crore;

AND

Securities with PE greater than 2 times PE of Benchmark Index (Nifty 500);

OR

Securities with negative PE, the following should be considered:

P/B (Price to Book) value of scrip greater than 2 times the P/B value of Benchmark Index (Nifty 500)

OR

P/B value is negative

Question 9

What is Additional Surveillance Measure (ASM)?

Accepted Answer

Additional Surveillance Measure (ASM) is part of SEBI and the Exchanges initiative to enhance market integrity and safeguard the interest of investors. The ASM list is a list of securities that are currently getting monitored due to factors like price fluctuation, volatility, volume variance, etc.

Question 10

What are the main objectives of and Additional Surveillance Measure (ASM)?

Accepted Answer

Alert and advice investors to be extra cautious while dealing in these securities.
Advise market participants to carry out necessary due diligence while dealing in these securities.

Question 11

Where can more details on Additional Surveillance Measure (ASM) be found?

Accepted Answer

FAQ booklet on ASM by BSE
ASM page on BSE website

Question 12

Should shortlisting under Additional Surveillance Measure (ASM) be construed as an adverse action against the concerned company/entity?

Accepted Answer

The shortlisting of securities under Additional Surveillance Measure (ASM) is purely on account of market surveillance and it should not be construed as an adverse action against the concerned company/entity.

Question 13

What are the criteria for shortlisting scrips under Additional Surveillance Measure (ASM) framework?

Accepted Answer

The shortlisting of securities for placing in Additional Surveillance Measure (ASM) framework is based on an objective criteria as jointly decided by SEBI and Exchanges covering the following market based dynamic parameters:

High Low Variation
Client Concentration
Close to Close Price Variation
Volume Variation
Delivery Percentage
No. of Unique PANs
PE

High Low Variation
Client Concentration
Close to Close Price Variation
Volume Variation
Delivery Percentage
No. of Unique PANs
PE

Exchange	Long/Short Term	Stage	Entry date	Exit date
BSE	GSM	Stage II	02 Apr 2025	04 Apr 2025
BSE	GSM	Stage I	01 Apr 2025	02 Apr 2025
BSE	GSM	Stage 0	18 Dec 2023	01 Apr 2025
BSE	GSM	Stage I	15 Dec 2023	18 Dec 2023
BSE	GSM	Stage II	10 Nov 2023	15 Dec 2023
BSE	GSM	Stage III	05 Oct 2023	10 Nov 2023
BSE	GSM	Stage II	04 Oct 2023	05 Oct 2023
BSE	GSM	Stage I	15 Sep 2023	04 Oct 2023
BSE	GSM	Stage II	11 Aug 2023	15 Sep 2023
BSE	GSM	Stage III	09 Jun 2023	11 Aug 2023
BSE	GSM	Stage II	06 Jun 2023	09 Jun 2023
BSE	GSM	Stage I	05 Jun 2023	06 Jun 2023
BSE	GSM	Stage 0	13 Apr 2023	05 Jun 2023
BSE	GSM	Stage I	14 Mar 2023	13 Apr 2023
BSE	GSM	Stage II	10 Feb 2023	14 Mar 2023
BSE	GSM	Stage III	23 Dec 2022	10 Feb 2023
BSE	GSM	Stage II	22 Dec 2022	23 Dec 2022
BSE	GSM	Stage I	13 Dec 2022	22 Dec 2022
BSE	GSM	Stage II	27 Oct 2022	13 Dec 2022
BSE	GSM	Stage I	20 Oct 2022	27 Oct 2022
BSE	GSM	Stage 0	07 Oct 2022	20 Oct 2022
BSE	GSM	Stage I	13 Sep 2022	07 Oct 2022
BSE	GSM	Stage II	05 Aug 2022	13 Sep 2022
BSE	GSM	Stage III	13 Jul 2022	05 Aug 2022
BSE	GSM	Stage II	12 Jul 2022	13 Jul 2022
BSE	GSM	Stage I	11 Jul 2022	12 Jul 2022
BSE	GSM	Stage 0	08 Jul 2022	11 Jul 2022
BSE	GSM	Stage I	06 May 2022	08 Jul 2022
BSE	GSM	Stage II	15 Mar 2022	06 May 2022
BSE	GSM	Stage III	10 Jan 2022	15 Mar 2022

Bacil Pharma Ltd. Additional Surveillance Measure (ASM) and Graded Surveillance Measure (GSM) as of Apr 05, 2025

History

FAQ